Navigation Links
OrthoAccel Technologies Committed to Plans for Positioning the United Kingdom as a Key Strategic Market for New Orthodontic Technology
Date:9/15/2010

HOUSTON, Sept. 15 /PRNewswire/ -- OrthoAccel Technologies, Inc. has announced commercial plans for the United Kingdom that entail considerable business activity and economic impact.  Last year, the Company hired a Director of Sales based in Wales.  Recently, a full-market UK release of the AcceleDent System was reported.  In conjunction with this product introduction at the British Orthodontic Conference, OrthoAccel has publicized plans to host a private lecture and reception to provide scientific data and education to doctors on this new technology that shortens orthodontic treatment time.

(Photo: http://photos.prnewswire.com/prnh/20100915/DA64878)

(Photo: http://www.newscom.com/cgi-bin/prnh/20100915/DA64878)

(Logo: http://photos.prnewswire.com/prnh/20091029/DA01250LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO)

AcceleDent is a simple, removable dental device that patients place in the mouth for twenty minutes daily.  It produces a gentle vibrational force which enhances the pressure applied by braces.  AcceleDent has been clinically proven to safely speed up orthodontic tooth movement.  The product is hands-free and allows the user flexibility to carry out most routine tasks during use.  

Mike Kaufman, VP of Marketing and Business Development at OrthoAccel explained, "We really made every effort to develop an easy-to-use device that would fit into a patient's daily routine with no trouble or inconvenience."  

And patients agree that the Company has accomplished just that.

"I am usually watching television or reading journals whilst using AcceleDent," reported one adult patient, who is a physician and under the care of Dr Asif Chatoo, a London-based orthodontic specialist.  She continued, "I am extremely pleased with my orthodontic treatment and feel that AcceleDent has helped me achieve the cosmetic result I hoped for in a short time period.  I absolutely would recommend it to someone undergoing orthodontic treatment."

So now that AcceleDent, which was made available last year to a select group of orthodontic specialists, will be available to all orthodontists in the United Kingdom, what comes next?

"We view the UK as a very important strategic market," shared Mike Lowe, CEO of OrthoAccel.  "We anticipate continued investment in a country that we consider a critical entry point into the EU Region.  In addition to our sales and marketing investment, we are currently conducting analysis as to the most effective way of establishing a corporate presence and true legal entity in the UK.  Since our founding in 2007, and through our development stage, we have created a number of jobs here in the states, and the prospect of crafting economic value in other parts of the world as well is very exciting."

That value, however, is not limited to commercialization.

"We are also currently in the process of partnering with a renowned dental hospital to conduct a clinical trial in the UK as early as 2011," added Kaufman.  "We intend to build the reputation of AcceleDent and our company OrthoAccel on clinical outcome studies that add to the body of evidence based medicine. "

OrthoAccel is anticipating the conclusion of another US clinical trial at the UT Health Science Center in San Antonio with a target completion date later in 2010.  

About OrthoAccel Technologies, Inc.

Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.  

About the AcceleDent System

AcceleDent represents the first clinical approach to safely accelerate orthodontic tooth movement via modulating biology.  The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling.  Importantly, the device works complementary with all existing orthodontic technologies.  AcceleDent is neither FDA cleared nor FDA approved; it is currently investigational only in the United States.  More information can be found at www.acceledent.com or requested via info@orthoaccel.com


'/>"/>
SOURCE OrthoAccel Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. OrthoAccel Technologies Announces Full-Market Release of AcceleDent, a New Technology to Shorten Treatment Time in Braces
2. OrthoAccel Technologies, Inc. Announces Definitive Distribution Agreements in Two Key Markets
3. OrthoAccel Technologies, Inc. and AB Orthodontics Announce Partnership and Australian Product Introduction
4. Celsis IVT Wins Preliminary Injunction Against Life Technologies and CellzDirect in Liverpool™ Patent Infringement Lawsuit
5. Palatin Technologies to Present at Rodman & Renshaw Annual Global Investment Conference
6. To Reach, Perchance to Kill the Cancer: A Soliloquy From Epeius Nanotechnologies Opposes That Sea of Troubles
7. BioStorage Technologies Appoints New Global Director of Supply Chain
8. Reportlinker Adds Cell Therapy - Technologies, Markets and Companies
9. Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies
10. Reportlinker Adds Transdermal Drug Delivery - Technologies, Markets, and Companies
11. Medisafe 1 Technologies Clarifies the PR Issued on September 1 for the Stock Dividend, as a Forward Split of 5-1 in the Form of a Stock Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... OAKLAND, N.J. , June 24, 2016 /PRNewswire/ ... in the design, development and manufacturing of collagen ... and regeneration announced today that Bill Messer ... Sales and Marketing to further leverage the growing ... surgery medical devices. Bill joins the ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Final Cut Pro X users can now reveal the media of their split ...
(Date:6/27/2016)... , ... June 27, 2016 ... ... the patient payment industry today announced its strategic partnership with Connance, a ... workflows. , The two companies’ proven, proprietary technology combine to provide health ...
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... ... 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment ... Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This ... of the world’s leading providers of cereal and other breakfast foods. Its residents often ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
Breaking Medicine News(10 mins):